A Risk Stratified Sequential Treatment With Rituximab, Brentuximab Vedotin and Bendamustine (RBvB)

Clinical trial NCT04138875 · WITHDRAWN

Trial details

NCT number: NCT04138875
Sponsor: Yale University
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

PTLD Lymphoid Tumor Hematopoietic/Lymphoid Cancer Plasmacytic Hyperplasia PTLD Infectious Mononucleosis Florid Follicular Hyperplasia PTLD Polymorphic PTLD Monomorphic PTLD Classical Hodgkin Lymphoma Type PTLD

Start date: 2022-01-01
Primary completion: 2023-09-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.